2005
DOI: 10.1111/j.1537-2995.2005.00215.x
|View full text |Cite
|
Sign up to set email alerts
|

A randomized crossover trial comparing three plateletpheresis machines

Abstract: The Accel is the fastest and, because of this advantage, the machine preferred by donors. The Amicus was the most efficient and the MCS Plus was the only one not to underestimate the processing time.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

10
50
1

Year Published

2006
2006
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(61 citation statements)
references
References 26 publications
(41 reference statements)
10
50
1
Order By: Relevance
“…This was attained by performing all collections using the same staff and donors as well as similar definitions and target endpoints on each instrument. Confirming previous reports [16,21,25], PLT loss was lowest with TA and highest with AM. The latter, however, returned additional saline solution that could have caused higher dilution of the donors' peripheral blood, thus mimicking an increased PLT loss.…”
Section: Discussionsupporting
confidence: 80%
See 2 more Smart Citations
“…This was attained by performing all collections using the same staff and donors as well as similar definitions and target endpoints on each instrument. Confirming previous reports [16,21,25], PLT loss was lowest with TA and highest with AM. The latter, however, returned additional saline solution that could have caused higher dilution of the donors' peripheral blood, thus mimicking an increased PLT loss.…”
Section: Discussionsupporting
confidence: 80%
“…Because CE depends markedly on preprocedure donor characteristics irrespective of procedure time, CR probably appears to be a more practical way of comparing PLT apheresis systems because it addresses both, PLT yield and time, considered today as important as yield when evaluating equipment. In a recent report, a short NT was the most highly valued measure for donors when choosing a cell separator, and, as a result, crucially important for donor recruitment and retention [25]. Therefore, the higher CRs of AM and TA in particular leading to shorter NTs compared to our current equipment must be considered as real improvement, whereas the lower CRs and longer NTs of MCS+ procedures were a real drawback as also described previously [37].…”
Section: Discussionmentioning
confidence: 85%
See 1 more Smart Citation
“…In our previously reported study [4], the donations were individually tailored in order to obtain the highest number of standard units containing 2 × 10 11 PLT within 100 min. This acceptable duration of donations up to 100 min results in a reduction of the ratio between the initial period (adjustment of interface) and the consecutive stable collection phase and therefore in a higher CR [3,4,7]. However, the donationinduced decrease of the donor's circulating PLT count may represent a safety limit for the production of multiple PLT concentrates.…”
Section: Methodsmentioning
confidence: 99%
“…Simultaneously, the Amicus cell separator was developed (A, Fenwal Division, Baxter, Deerfield, IL), which uses plasma recirculation to collect WBC‐reduced PLT concentrates and plasma within shorter collection times than with the previous instrument (CS‐3000 Plus, Fenwal Division, Baxter). Two recent comparisons of both new cell separators have been published: Burgstaler and coworkers 6 have primarily addressed the PLT yields, collection efficiencies, residual numbers of WBCs, and processing times, whereas Bueno and coworkers 7 looked for the processing times required to obtain a 3.5 × 10 11 PLT concentrate and the acceptance by donors. Both devices showed high levels of safety and efficacy as preconditions for the production of multiple PLT concentrates from a single donation.…”
mentioning
confidence: 99%